Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research

被引:506
作者
Lewis, James D.
Schinnar, Rita
Bilker, Warren B.
Wang, Xingmei
Strom, Brian L.
机构
[1] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
medical records database; database validation; case-control studies;
D O I
10.1002/pds.1335
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background The Health Improvement Network (THIN) is a new medical records database that contains records from general practices some of which have or continue to participate in the General Practice Research Database (GPRD) and others that never participated in GPRD. We sought to replicate in THIN well-established associations from the medical literature and to compare results from the GPRD practices to the non-GPRD practices within THIN. Methods Using THIN data from 1986-2003, we conducted case-control studies of associations between diseases (e.g., hypertension and stroke) and between diseases and drugs (e.g., aspirin and colon cancer). Conditional logistic regression was used to calculate odds ratios adjusted for potential confounders. Differences between GPRD and non-GPRD practices were assessed by testing for a statistical interaction by practice type in each outcome-exposure association. Results We observed the expected positive associations (p < 0.05) of stroke with hypertension and diabetes mellitus; of myocardial infarction with hypertension, hypercholesterolemia, obesity, and smoking; and of peptic ulcer disease with aspirin, NSAIDs, and potassium. We observed. the expected negative associations (p < 0.05) of colorectal cancer with aspirin, NSAIDs, and cox-2 inhibitors. The expected protective effect of aspirin use for myocardial infarction was not observed. In all cases, the results obtained from the GPRD practices were similar to the results obtained from the non-GPRD practices, only being statistically different for the associations of myocardial infarction with diabetes and aspirin use. Conclusions THIN data that are collected outside of the GPRD appear as valid as the data collected as part of the GPRD. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:393 / 401
页数:9
相关论文
共 11 条
  • [1] [Anonymous], 1998, Modern Epidemiology
  • [2] De Wilde S, 2004, Health Stat Q, P21
  • [3] Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4)
    Hansell, A
    Hollowell, J
    Nichols, T
    McNiece, R
    Strachan, D
    [J]. THORAX, 1999, 54 (05) : 413 - 419
  • [4] Hollowell J, 1997, Popul Trends, P36
  • [5] Hosmer W., 2000, Applied Logistic Regression, VSecond
  • [6] Validity of the General Practice Research Database
    Jick, SS
    Kaye, JA
    Vasilakis-Scaramozza, C
    Rodríguez, LAG
    Ruigómez, A
    Meier, CR
    Schlienger, RG
    Black, C
    Jick, H
    [J]. PHARMACOTHERAPY, 2003, 23 (05): : 686 - 689
  • [7] Validation of the diagnosis of venous thromboembolism in general practice database studies
    Lawrenson, R
    Todd, JC
    Leydon, GM
    Williams, TJ
    Farmer, RDT
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (06) : 591 - 596
  • [8] Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease
    Lewis, JD
    Brensinger, C
    Bilker, WB
    Strom, BL
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (03) : 211 - 218
  • [9] The relationship between time since registration and measured incidence rates in the General Practice Research Database
    Lewis, JD
    Bilker, WB
    Weinstein, RB
    Strom, BL
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (07) : 443 - 451
  • [10] Rodríguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419